Aim is to combine the benefits of mutual technologies to enable higher quality cells at a lower cost Collaboration is in line with Cellect’s strategy to provide wide scale standardization, aimed at benefiting multiple stem cell therapy products covering a wide range of diseases TEL AVIV, Israel — Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel […]
Cambridge, UK: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today thatTris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development and help translate its technology to an industrial context. Sphere Fluidics develops […]
MINNEAPOLIS — Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies. Bio-Techne has a highly-qualified team who have full control over the cGMP process, meaning we can ensure: a quality assured manufacturing system, […]
Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering […]
Two Leading Centers to Explore Spatial Genomics Synergies with Single-Cell Biology, Next-Generation Sequencing, and Advanced Imaging Technologies Announces Early Access Launch for Five Additional Beta Instruments SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company has added two new Centers of Excellence […]
Includes growth equity investment from Ampersand Capital Partners MEMPHIS, TN and BOTHEL, WA – Key Biologics, has completed its merger with Astarte Biologics to create the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry. In conjunction with the merger the new entity also received an investment from Ampersand […]
MELVILLE, N.Y. — Nikon Instruments Inc., innovator of advanced optical instruments, today announced the release of the latest in its line of state-of the art tools. The N-SIM S Super Resolution Microscope enables super-solution imaging of live cells at ten-times the speed of conventional SIM. Powered at its core by the ECLIPSE Ti2-E Inverted Research Microscope, the N-SIM […]
Group sales of EUR 335.6 million with organic growth of 8.6 percent in local currencies Operating result increases by 6.4 percent to EUR 67.3 million; EBIT margin of 20.0 percent Enhancements in sales & distribution and accelerated innovation are confirmed as success factors Hamburg – The Eppendorf Group continued to perform well in the first […]
The ARTOS 3D ultramicrotome expands 3D image reconstruction applications for cell biology research Wetzlar, Germany. The new ARTOS 3D ultramicrotome is a powerful ARray TOmography Solution for 3D imaging applications from Leica Microsystems. It marks a new level of quality and speed for ultramicrotome sectioning intended for 3D tomography with a light or scanning electron […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Exosome Diagnostics, Inc. The transaction consideration includes an upfront payment of $250 million plus an additional $325 million that can be maximally earned through calendar year 2022 upon reaching certain performance milestones. With this acquisition, Minneapolis-based Bio-Techne now has a world-wide workforce […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
